Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir
ACS Pharmacology & Translational Science · 13.02.2026 · 9 (2) · 404-413
DOI: 10.1021/acsptsci.5c00681 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 28.01.2026. Verfasst von Haozhou Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States.
- Department of Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, Oklahoma 74078, United States.
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma 74078, United States.
ORCID-Profile: Xufang Deng, Jun Wang
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Tan, H., Chi, X., Deng, X., & Wang, J. (2026). Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir. ACS Pharmacology & Translational Science, 9(2), 404-413. https://doi.org/10.1021/acsptsci.5c00681
Vancouver
Tan H, Chi X, Deng X, Wang J. Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir. ACS Pharmacology & Translational Science. 2026;9(2):404-413. doi:10.1021/acsptsci.5c00681
BibTeX
@article{Tan2026,
author = {Tan, Haozhou and Chi, Xiang and Deng, Xufang and Wang, Jun},
title = {Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {2},
pages = {404--413},
doi = {10.1021/acsptsci.5c00681}
}
EUVIMED